SA
SRTAW

Sanctuary Advisors’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Sanctuary Advisors’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-238,588
Closed -$62.5K – 2463
2024
Q2 		$62.5K Buy
+238,588
New +$61.3K ﹤0.01% 2284

Other funds holding SRTAW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sanctuary Advisors's SRTAW Position: Q3 2024 in Review

Sanctuary Advisors sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q3 2024, closing a stake of 238,588 shares — an estimated $62.5K sold.

Sanctuary Advisors first reported a position in SRTAW in Q2 2024 and held it in 1 quarter. The position peaked at $62.5K in Q2 2024. 8 funds tracked by Wall St. Rank hold SRTAW as of Q3 2024.

  • Sanctuary Advisors reported no remaining Strata Critical Medical Inc Warrants position as of Q3 2024 after selling out during the quarter.
  • Sanctuary Advisors sold 238,588 Strata Critical Medical Inc Warrants shares in Q3 2024, an estimated $62.5K.
  • Sanctuary Advisors first reported a position in Strata Critical Medical Inc Warrants in Q2 2024 and held it in 1 quarter.
  • Sanctuary Advisors's Strata Critical Medical Inc Warrants position peaked at $62.5K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q3 2024.

Based on Sanctuary Advisors's 13F filing for Q3 2024, filed 25 Nov 2024.